ALLMedicine™ Hepatitis B Virus Center
Research & Reviews 17,545 results
https://doi.org/10.1186/s12879-020-05713-0
BMC Infectious Diseases; Wang R, Zhang D et. al.
Jan 13th, 2021 - Hepatitis B virus (HBV) infection is a high-risk factor of hepatocellular carcinoma (HCC). Cellular immune responses are essential for HCC development, and the CD4+ and CD8+ T subtypes are identified as the primary anti-tumor immune cells. In the ...
https://doi.org/10.1186/s12985-021-01487-2 10.1007/s00281-012-0327-7 10.1016/j.jhep.2019.03.034 10.1186/s12882-015-0010-z 10.1002/jmv.21121 10.1016/S1473-3099(02)00345-6 10.1111/liv.12324 10.1055/s-0039-1678728 10.3748/wjg.v17.i15.1927 10.1128/CMR.00018-11 10.3349/ymj.2017.58.3.557 10.1016/S2468-1253(18)30002-5 10.1007/s00535-016-1273-2 10.1186/1743-422X-7-324 10.1016/j.jhep.2013.05.043 10.3748/wjg.v21.i42.11931 10.1006/viro.1999.9833 10.1016/S0168-8278(01)00264-1 10.1128/JVI.79.5.3038-3051.2005 10.1111/j.1440-1746.2011.06940.x 10.1016/j.patbio.2009.11.001 10.1111/j.1478-3231.2012.02764.x 10.1159/000329809 10.1038/cddis.2013.219 10.1038/cti.2016.68 10.4049/jimmunol.1103139 10.1016/j.jviromet.2018.03.001 10.1080/10635150600755453 10.1590/S0100-879X2006005000197 10.1590/S0004-28032007000100013 10.1111/hdi.12285 10.1111/j.1440-1746.2009.05972.x 10.1590/S0100-879X2006000400013 10.1111/j.1399-3062.2005.00091.x 10.1016/j.virusres.2017.09.022 10.1053/jhep.2001.28708 10.1016/S0140-6736(05)17961-6 10.3350/kjhep.2008.14.1.67 10.7150/jca.6609 10.1111/j.1478-3231.2011.02481.x 10.3748/wjg.v17.i12.1558 10.1002/1096-9071(200103)63:3<220::AID-JMV1004>3.0.CO;2-3 10.1002/(SICI)1096-9071(199907)58:3<201::AID-JMV3>3.0.CO;2-2 10.1016/S0168-8278(00)80311-6 10.1016/S0168-8278(00)00100-8 10.1111/j.1572-0241.2000.03371.x 10.1002/jmv.1057 10.1016/j.cyto.2009.06.005 10.1590/S0074-02762011000800018 10.1016/j.humimm.2014.08.198 10.3748/wjg.v12.i3.482 10.1016/j.cyto.2017.04.008 10.1098/rsob.190109 10.1016/j.autrev.2012.05.004 10.1002/hep.23273 10.1111/j.1537-2995.2012.03575.x 10.1111/imm.12720 10.1097/QAD.0000000000000654 10.1016/j.virol.2015.02.026 10.1146/annurev.immunol.17.1.701 10.4238/2014.November.27.2 10.1016/j.jhep.2011.11.011
Virology Journal; Ribeiro CRA, de Almeida NAA et. al.
Jan 13th, 2021 - The hepatitis B virus (HBV) is one of the leading causes of acute, chronic and occult hepatitis (OBI) representing a serious public health threat. Cytokines are known to be important chemical mediators that regulate the differentiation, proliferat...
https://doi.org/10.1371/journal.pone.0244939
PloS One; Yen YH, Cheng YF et. al.
Jan 13th, 2021 - A recent study from the United States reported that nearly 12% of hepatocellular carcinomas (HCCs) occurred in patients without cirrhosis. Non-alcoholic fatty liver disease (NAFLD) was the most common liver disease in these patients. We aim to eva...
https://doi.org/10.1007/s10620-020-06745-x 10.3322/caac.21395 10.3322/caac.21457 10.1056/NEJMoa1315870 10.1056/NEJMoa1100370 10.1016/S0022-3999(00)00155-0 10.1002/hep.1840360621 10.1016/j.amjmed.2004.01.023 10.1016/j.cld.2004.02.003 10.1016/j.jhep.2005.11.046 10.1053/j.gastro.2016.02.039 10.1007/s00384-013-1763-0 10.21037/jgo.2016.03.11 10.1002/hep.30034 10.1016/j.amjms.2018.04.016 10.4103/0973-1482.174544 10.1001/jamanetworkopen.2019.5718 10.1111/liv.14305 10.3390/v12010097 10.1016/j.gie.2016.12.009 10.1001/jama.283.15.2008 10.1136/bmj.g7647 10.1136/bmj.327.7414.557 10.1002/9781119536604 10.4143/crt.2018.143 10.1046/j.1365-2168.2002.02120.x 10.1016/j.cgh.2010.10.014 10.1111/j.1440-1746.2009.06117.x 10.1111/j.1440-1746.2011.06816.x 10.1007/s11901-018-0403-0 10.1128/JVI.69.6.3893-3896.1995 10.2119/2006-00020.Wu 10.1111/j.1872-034X.2007.00261.x 10.1016/j.canlet.2010.09.018 10.1002/1097-0142(19920915)70:4+<1727::AID-CNCR2820701613>3.0.CO;2-P 10.1007/978-1-4419-1145-2_8 10.1002/hep.1840180406 10.1371/journal.pone.0181683 10.1099/jmm.0.000272
Digestive Diseases and Sciences; Hong SW, Choi WM et. al.
Jan 12th, 2021 - Chronic viral hepatitis is associated with a wide range of extrahepatic diseases; however, evidence on a link between chronic viral hepatitis and colorectal neoplasia is still lacking. To analyze the association between chronic viral hepatitis and...
https://doi.org/10.1007/s10620-020-06764-8 10.1055/s-2008-1040318 10.1056/NEJMra0901512 10.1016/j.gie.2006.08.023 10.1016/j.cgh.2019.01.025 10.1002/hep.28906 10.1016/j.jhep.2016.09.027 10.1016/j.jhep.2015.05.022 10.1016/j.jhep.2018.04.023 10.1002/hep.30522 10.1136/gutjnl-2015-309741 10.14309/ajg.0000000000000266 10.1111/liv.13379 10.4254/wjh.v7.i17.2069 10.1016/j.jhep.2013.04.010 10.1136/gut.2004.040832 10.3748/wjg.v21.i3.988 10.1002/hep.28824 10.1007/s10620-009-0887-0 10.1016/j.dld.2018.12.025 10.1111/liv.14036 10.1002/hep.29363 10.1038/s41395-018-0265-7
Digestive Diseases and Sciences; Yan Y, Xing X et. al.
Jan 12th, 2021 - A large portion of patients with compensated advanced chronic liver disease (cACLD) do not have varices or only have low risk varices. To create and validate an easy-to-use risk scoring system to identify high-risk varices (HRV) and spare esophago...
Guidelines 47 results
https://ascopubs.org/doi/full/10.1200/JCO.20.01757
Journal of Clinical Oncology; Hwang JP
Jul 26th, 2020 - This Provisional Clinical Opinion update presents a clinically pragmatic approach to hepatitis B virus (HBV) screening and management.
https://doi.org/10.1080/23744235.2019.1675903
Infectious Diseases (London, England); Westin J, Aleman S et. al.
Oct 15th, 2019 - Despite access to effective antiviral drugs and vaccines, hepatitis B virus (HBV) infection remains a major health issue worldwide. HBV is highly infectious and may cause chronic infection, progressive liver damage, hepatocellular cancer (HCC) and...
https://jamanetwork.com/journals/jama/fullarticle/2738558
JAMA
Jul 22nd, 2019 - Screening for hepatitis B virus (HBV) infection during pregnancy identifies women whose infants are at risk of perinatal transmission. Data from a nationally representative sample showed a prevalence of maternal HBV infection of 85.8 cases per 100...
https://jamanetwork.com/journals/jama/fullarticle/2738527
JAMA
Jul 22nd, 2019 - Contemporary clinicians who provide obstetric care acknowledge screening of pregnant women for perinatally transmissible infectious diseases as a routine component of prenatal care,1 although this has not always been the case. For example, prenata...
https://jnccn.org/view/journals/jnccn/17/4/article-p302.xml
Benson,A.,et al
Mar 31st, 2019 - Incidence and mortality rates for cancer overall are declining, but both incidence and mortality rates for hepatocellular carcinoma (HCC) are increasing.1,2 Risk factors for development of HCC include infection with hepatitis B virus (HBV) and/or ...
Drugs 19 results see all →
Clinicaltrials.gov 17,895 results
https://doi.org/10.1186/s12879-020-05713-0
BMC Infectious Diseases; Wang R, Zhang D et. al.
Jan 13th, 2021 - Hepatitis B virus (HBV) infection is a high-risk factor of hepatocellular carcinoma (HCC). Cellular immune responses are essential for HCC development, and the CD4+ and CD8+ T subtypes are identified as the primary anti-tumor immune cells. In the ...
https://doi.org/10.1186/s12985-021-01487-2 10.1007/s00281-012-0327-7 10.1016/j.jhep.2019.03.034 10.1186/s12882-015-0010-z 10.1002/jmv.21121 10.1016/S1473-3099(02)00345-6 10.1111/liv.12324 10.1055/s-0039-1678728 10.3748/wjg.v17.i15.1927 10.1128/CMR.00018-11 10.3349/ymj.2017.58.3.557 10.1016/S2468-1253(18)30002-5 10.1007/s00535-016-1273-2 10.1186/1743-422X-7-324 10.1016/j.jhep.2013.05.043 10.3748/wjg.v21.i42.11931 10.1006/viro.1999.9833 10.1016/S0168-8278(01)00264-1 10.1128/JVI.79.5.3038-3051.2005 10.1111/j.1440-1746.2011.06940.x 10.1016/j.patbio.2009.11.001 10.1111/j.1478-3231.2012.02764.x 10.1159/000329809 10.1038/cddis.2013.219 10.1038/cti.2016.68 10.4049/jimmunol.1103139 10.1016/j.jviromet.2018.03.001 10.1080/10635150600755453 10.1590/S0100-879X2006005000197 10.1590/S0004-28032007000100013 10.1111/hdi.12285 10.1111/j.1440-1746.2009.05972.x 10.1590/S0100-879X2006000400013 10.1111/j.1399-3062.2005.00091.x 10.1016/j.virusres.2017.09.022 10.1053/jhep.2001.28708 10.1016/S0140-6736(05)17961-6 10.3350/kjhep.2008.14.1.67 10.7150/jca.6609 10.1111/j.1478-3231.2011.02481.x 10.3748/wjg.v17.i12.1558 10.1002/1096-9071(200103)63:3<220::AID-JMV1004>3.0.CO;2-3 10.1002/(SICI)1096-9071(199907)58:3<201::AID-JMV3>3.0.CO;2-2 10.1016/S0168-8278(00)80311-6 10.1016/S0168-8278(00)00100-8 10.1111/j.1572-0241.2000.03371.x 10.1002/jmv.1057 10.1016/j.cyto.2009.06.005 10.1590/S0074-02762011000800018 10.1016/j.humimm.2014.08.198 10.3748/wjg.v12.i3.482 10.1016/j.cyto.2017.04.008 10.1098/rsob.190109 10.1016/j.autrev.2012.05.004 10.1002/hep.23273 10.1111/j.1537-2995.2012.03575.x 10.1111/imm.12720 10.1097/QAD.0000000000000654 10.1016/j.virol.2015.02.026 10.1146/annurev.immunol.17.1.701 10.4238/2014.November.27.2 10.1016/j.jhep.2011.11.011
Virology Journal; Ribeiro CRA, de Almeida NAA et. al.
Jan 13th, 2021 - The hepatitis B virus (HBV) is one of the leading causes of acute, chronic and occult hepatitis (OBI) representing a serious public health threat. Cytokines are known to be important chemical mediators that regulate the differentiation, proliferat...
https://doi.org/10.1371/journal.pone.0244939
PloS One; Yen YH, Cheng YF et. al.
Jan 13th, 2021 - A recent study from the United States reported that nearly 12% of hepatocellular carcinomas (HCCs) occurred in patients without cirrhosis. Non-alcoholic fatty liver disease (NAFLD) was the most common liver disease in these patients. We aim to eva...
https://doi.org/10.1007/s10620-020-06745-x 10.3322/caac.21395 10.3322/caac.21457 10.1056/NEJMoa1315870 10.1056/NEJMoa1100370 10.1016/S0022-3999(00)00155-0 10.1002/hep.1840360621 10.1016/j.amjmed.2004.01.023 10.1016/j.cld.2004.02.003 10.1016/j.jhep.2005.11.046 10.1053/j.gastro.2016.02.039 10.1007/s00384-013-1763-0 10.21037/jgo.2016.03.11 10.1002/hep.30034 10.1016/j.amjms.2018.04.016 10.4103/0973-1482.174544 10.1001/jamanetworkopen.2019.5718 10.1111/liv.14305 10.3390/v12010097 10.1016/j.gie.2016.12.009 10.1001/jama.283.15.2008 10.1136/bmj.g7647 10.1136/bmj.327.7414.557 10.1002/9781119536604 10.4143/crt.2018.143 10.1046/j.1365-2168.2002.02120.x 10.1016/j.cgh.2010.10.014 10.1111/j.1440-1746.2009.06117.x 10.1111/j.1440-1746.2011.06816.x 10.1007/s11901-018-0403-0 10.1128/JVI.69.6.3893-3896.1995 10.2119/2006-00020.Wu 10.1111/j.1872-034X.2007.00261.x 10.1016/j.canlet.2010.09.018 10.1002/1097-0142(19920915)70:4+<1727::AID-CNCR2820701613>3.0.CO;2-P 10.1007/978-1-4419-1145-2_8 10.1002/hep.1840180406 10.1371/journal.pone.0181683 10.1099/jmm.0.000272
Digestive Diseases and Sciences; Hong SW, Choi WM et. al.
Jan 12th, 2021 - Chronic viral hepatitis is associated with a wide range of extrahepatic diseases; however, evidence on a link between chronic viral hepatitis and colorectal neoplasia is still lacking. To analyze the association between chronic viral hepatitis and...
https://doi.org/10.1007/s10620-020-06764-8 10.1055/s-2008-1040318 10.1056/NEJMra0901512 10.1016/j.gie.2006.08.023 10.1016/j.cgh.2019.01.025 10.1002/hep.28906 10.1016/j.jhep.2016.09.027 10.1016/j.jhep.2015.05.022 10.1016/j.jhep.2018.04.023 10.1002/hep.30522 10.1136/gutjnl-2015-309741 10.14309/ajg.0000000000000266 10.1111/liv.13379 10.4254/wjh.v7.i17.2069 10.1016/j.jhep.2013.04.010 10.1136/gut.2004.040832 10.3748/wjg.v21.i3.988 10.1002/hep.28824 10.1007/s10620-009-0887-0 10.1016/j.dld.2018.12.025 10.1111/liv.14036 10.1002/hep.29363 10.1038/s41395-018-0265-7
Digestive Diseases and Sciences; Yan Y, Xing X et. al.
Jan 12th, 2021 - A large portion of patients with compensated advanced chronic liver disease (cACLD) do not have varices or only have low risk varices. To create and validate an easy-to-use risk scoring system to identify high-risk varices (HRV) and spare esophago...
News 391 results
https://www.medscape.com/viewarticle/942681
Dec 15th, 2020 - NEW YORK (Reuters Health) - The U.S. Preventive Services Task Force (USPSTF) continues to recommend screening for hepatitis B virus (HBV) in nonpregnant adolescents and adults at increased risk for HBV infection, concluding with "moderate certaint...
https://www.staging.medscape.com/viewarticle/936294
Aug 25th, 2020 - NEW YORK (Reuters Health) - Patients with chronic hepatitis B who have undetectable serum hepatitis B virus (HBV) RNA can safely undergo cessation of entecavir antiviral treatment, according to a new study. "Serum HBV RNA reflects an important int...
https://www.medscape.com/viewarticle/936294
Aug 25th, 2020 - NEW YORK (Reuters Health) - Patients with chronic hepatitis B who have undetectable serum hepatitis B virus (HBV) RNA can safely undergo cessation of entecavir antiviral treatment, according to a new study. "Serum HBV RNA reflects an important int...
https://www.medscape.com/viewarticle/935890
Aug 18th, 2020 - NEW YORK (Reuters Health) - In HIV/hepatitis B virus (HBV)-coinfected individuals with renal dysfunction, renal function improves after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF), according to results from a ...
https://www.staging.medscape.com/viewarticle/935890
Aug 18th, 2020 - NEW YORK (Reuters Health) - In HIV/hepatitis B virus (HBV)-coinfected individuals with renal dysfunction, renal function improves after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF), according to results from a ...
